Insider · CIK 0001213308
Immanuel Thangaraj
Files at ACUR (ACURA PHARMACEUTICALS, INC). First filing -, latest -.
In brief
Immanuel Thangaraj files SEC Form 4 as director at ACUR (ACURA PHARMACEUTICALS, INC). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Immanuel Thangaraj has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 2, 2026 | ACUR ACURA PHARMACEUTICALS, INC | MOption exercise Common Stock | +50,000 | - | - | 547,647 | Jan 15, 2026 |
| Jan 2, 2026 | ACUR ACURA PHARMACEUTICALS, INC | MOption exercise Restricted Stock Units (2021 Plan)derivative | -50,000 | - | - | 0 | Jan 15, 2026 |
| Jan 2, 2026 | ACUR ACURA PHARMACEUTICALS, INC | AGrant or award Restricted Stock Units (2021 Plan)derivative | -50,000 | - | - | 50,000 | Jan 15, 2026 |
| Jan 2, 2025 | ACUR ACURA PHARMACEUTICALS, INC | MOption exercise Common Stock | +50,000 | - | - | 497,647 | Feb 4, 2025 |
| Jan 2, 2025 | ACUR ACURA PHARMACEUTICALS, INC | MOption exercise Restricted Stock Units (2021 Plan)derivative | -50,000 | - | - | 0 | Feb 4, 2025 |
| Jan 2, 2025 | ACUR ACURA PHARMACEUTICALS, INC | AGrant or award Restricted Stock Units (2021 Plan)derivative | -50,000 | - | - | 50,000 | Feb 4, 2025 |
Questions about Immanuel Thangaraj
Answered from the filings on this page, as of the latest one.
Is Immanuel Thangaraj buying or selling?
Immanuel Thangaraj has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Immanuel Thangaraj's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Immanuel Thangaraj has 0.
Where does Immanuel Thangaraj file Form 4?
Immanuel Thangaraj has filed Form 4 at ACUR (ACURA PHARMACEUTICALS, INC). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.